1. Stefan Gijssels, Janssen Pharmaceutica
Employer Branding
9/19/2018
Stefan Gijssels, Janssen Pharmaceutica

2. The most attractive employer?
9/19/2018

3. 9/19/2018

4. Sales Volume of Janssen Pharmaceutica N.V.
million euros
Sales Volume of Janssen Pharmaceutica N.V.
The sales volume, or turnover, has grown steadily over the years both in Belgium and abroad. In particular, the increase in exports in the past few years is striking.
Belgium:
1999: : : : : : 87
Abroad:
1999: 1, : 1, : 1, : 1, : 1, : 1,847
Total:
1999: 1, : 1, : 1, : 1, : 1, : 1,934

5. R&D Investments by Janssen Belgium
In millions of euro
9/19/2018

6. Employment at Janssen in Belgium
9/19/2018

7. Randstad survey : Most Attractive Employer Percentage of people that spontaneously mention they want to work for company X 1 2 3 1 3 1 1 3 4 7
Period of intense and pro-active media relations &
stakeholder engagement
Period of company reorganisation & reactive external outreach

8. The fundamental questions?
Who Are We?
How does the environment change?
Where do we go?
Who do we want to be?
How will we differentiate ourselves?
What are our values?
What do we want to achieve?
By when?
How will we measure success?
9/19/2018

9. Employer branding???? Which brand???
9/19/2018

10. 9/19/2018

11. 9/19/2018

13. We will tackle the five areas of high global unmet medical need
Neuroscience
Schizophrenia, bipolar, Alzheimer’s and pain
Breast, lung, prostate, B-cell malignancies, colorectal cancer
Oncology
Infectious Diseases
HIV/AIDS, Hepatitis C, tuberculosis and influenza
Rheumatoid arthritis, psoriasis and pulmonary diseases
Immunology
Heart disease, diabetes and obesity
Cardiovascular & Metabolism
9/19/2018

14. Vision & Mission
Janssen EMEA will lead fundamental change in the way diseases are managed
In our absolute commitment to patients, we will build innovative, integrated healthcare solutions that will restore and extend the quality of life, while at the same time creating economic value for society and our company.
We will achieve this by working side-by-side with healthcare stakeholders
We will focus our energy on five major therapeutic areas of unmet need:
Neuroscience (schizophrenia, dementia, pain …),
Infectious Diseases (HIV/AIDS, Hepatitis C, tuberculosis, …),
Oncology (multiple myeloma, prostate cancer, …),
Immunology (psoriasis, rheumatoid arthritis, …),
Metabolism (diabetes, obesity, …).
We will continue to invest in our people to realize their personal growth and to build our leaders of the future
9/19/2018

15. The world is our laboratory
We Will Find Best Innovation Wherever It Exists
Licensing and Acquisitions
Discovery
Early Development
Late Development
New Drug Application
Internal Research
The world is our laboratory
External Innovation
Academia Biotech Pharma Consortia
9/19/2018

16. Our aspiration Good for society Not good for society Unprofitable
Highly profitable
9/19/2018

17. Pharmaceutical companies : global ranking
Company
Total Revenues (US$ billions)
R&D Expenses (reported currency in millions) 1
Pfizer
50,01
$7,845 2
Roche
47,35
CHF 9,874 3
GlaxoSmithKline
45,83
£4,106 4
Novartis
44,27
$7,469 5
Sanofi-Aventis
41,99
€4,583 6
AstraZeneca
32,81
$4,409 7
Abbott Laboratories
30,76
$2,744 8
Merck & Co.
27,43
$5,800 9
Janssen
22,50
$4,591 10
Bayer HealthCare
22,30
€1,845 11
Eli Lilly
21,84
N/A 12
Bristol-Myers Squibb
18,81
$3,647
9/19/2018

18. The four P’s : excel in all areas
Product
People
Planet
Profit
GOALS
METRICS
PROGRAMS
High therapeutic added value
Cancer, Aids, alzheimer’s, diabetes, tuberculosis
Best talent, diversity, safety, training, career mentoring, ....
Sustainability programs, WWF Climate Champion, 100% green energy in Belgium, “Design For Environment”, ....
Challenging times, but excellent long-term perspectives
9/19/2018

19. Communications is key Job recruitment days Media relations
Company visits
Web-based communications
Sustainability reports
Lots and lots of direct engagement and contacts
“14 Imperatives of improved communications”
9/19/2018

20. New design and new materials
Company story
EMEA Intranet
Advertisements
EMEA website
They want to know who we are …
EMEA Newsletter
Screensaver
Videos
Posters
9/19/2018

21. 9/19/2018

22. Conclusion What is key in having a good employer branding :
Success salary, job security, long term perspective, innovation, training, ...
International career opportunities, self-development, ...
Proximity familiar, low threshold, ...
Values diversity, environment, workplace environment, safety, work-life balance, training, ...
9/19/2018

23. The most attractive employer!
9/19/2018

24. Thank You

25. Awards & Recognition
2009
Business & Society – Environment AWARD
EOS - Dr. Paul Janssen : Greatest Belgian Scientist
Award High Council for Prenvention & Safety at work
3C – IBIS Master Communicator Award
Global Ergonomics Cup
Agoria – Prevention Advisor Of The Year
European Quality Manager Of The Year
International Galien Award – Best Innovative Medicine
CCTV – Janssen China : Most Attractive Employer
Belgian Galien Award – Best Innovative Medicine
Paul Janssen – Greatest Belgian – second place
Trends – Ajit Shetty – Manager Of The Year
Datanews – ICT Manager Of The Year
IBIS Award 2008
2008
2007
2006
2005
Datanews ICT
Manager Of
The Year 2005
2004
9/19/2018

26. Janssen Pharmaceutica NV invests…
ePharm.ppt
9/19/2018 7:47:32 AM
Janssen Pharmaceutica NV invests…
in buildings, equipment and new technology
million euros
Janssen invests in buildings, equipment and new technology
The ever-increasing investments in buildings, equipment and new technology are essential to allow efficient and specialized work to continue into the future.